The proto-oncogene c-jun encodes a ubiquitously expressed protein, which is part of transcription factor AP-1 and mediates gene expression following a variety of extracellular stimuli, including the action of growth factors, lymphokines, tumor necrosis factor-a, phorbolesters and stress induced by u.v. irradiation (reviewed in Angel and Karin, 1991) . A role of c-JUN in cellular growth control has been documented in several model systems: c-JUN is rapidly induced as quiescent fibroblasts are stimulated to proliferate (Ryseck et al., 1988) and plays an important role in cell cycle progression (Kovary and Bravo, 1991) . Null mutations of the c-jun locus in the mouse result in loss of viability at midgestation and primary jun 7/7 ®broblasts have retarded growth rates in culture (Johnson et al., 1993) .
Subcutaneous injection of embryonic stem cells lacking functional c-JUN leads to a reduction in the formation of teratosarcomas as compared to jun +/+ and jun +/7 ES cells, suggesting that functional c-JUN is essential for ecient tumor growth in vivo (Hilberg and Wagner, 1992) . Overexpression of c-jun in primary rat embryo cells results in malignant transformation in cooperation with activated Ha-Ras (SchuÈ tte et al., 1989) . Constitutive high AP-1 activity was observed in malignant mouse keratinocytes (Domann et al., 1994b) and stable expression of a dominant negative c-jun mutant in these cancer cells eciently blocked tumor formation in vivo (Domann et al., 1994a) . At present it is not clear how c-JUN contributes to tumorigenesis: overexpression of c-jun could increase proliferation and/or inhibit terminal dierentiation of cells.
In this communication we have used normal human keratinocytes (NHK) and malignant keratinocytes derived from squamous cell carcinoma (SCC) to investigate the eect of ectopically expressed c-jun or of a dominant negative mutant of c-jun on keratinocyte terminal dierentiation. The small proline rich protein 2 (SPRR2), a corni®ed cell envelope precursor (Hohl et al., 1995; Steinert and Marekov, 1995) , whose expression is restricted to terminally dierentiated keratinocytes, was used as a marker for terminal dierentiation. Immuno-histochemical analysis of strati®ed cultures of normal human keratinocytes revealed that SPRR2 proteins are located in the cytoplasm and cell periphery of suprabasal, differentiating keratinocytes whereas c-JUN is detected in the nuclei of cells in the basal, proliferating layer ( Figure  1a) . Similarly, when keratinocyte cultures were induced to stratify and terminally dierentiate by increasing the calcium concentration of the medium (Fischer et al., 1996) , a clear decrease of c-jun expression is observed, whereas expression of sprr2 is strongly induced ( Figure  1b) . The slight induction of c-jun, at 1 h after the calcium switch, is likely related to cell proliferation which accompanies keratinocyte strati®cation (Watt et al., 1991) . Overall our analysis indicates that during keratinocyte terminal dierentiation the expression of the c-jun and sprr2 genes are inversely related.
A similar inverse relation is also observed in several malignant keratinocyte lines, derived from squamous cell carcinoma (Rheinwald and Beckett, 1981) . In these cells sprr2 expression is clearly decreased (Figure 2A ), consistent with their inherent defect in terminal dierentiation (Rheinwald and Beckett, 1980) . Conversely, c-jun expression is increased as compared to normal human keratinocytes ( Figure 2B ). These results prompted us to analyse whether a direct relation exists between c-JUN, a transcriptional regulator, and the expression of the SPRR2 terminal dierentiation marker.
That c-JUN is indeed capable of interfering directly with transcription of sprr2 was shown by the following experiments. In NHK, ectopic expression of c-jun, under the control of the strong RSV promoter, inhibits dierentiation speci®c sprr2a promoter activity ( Figure  3A , bar 5). This inhibition was not observed with the control vector (bar 3) nor with a construct expressing a mutant c-JUN protein (bar 4). Apparently the high expression levels of c-jun, as found in basal keratinocytes, have to be down-regulated in order to allow expression of the SPRR2 terminal dierentiation marker. To analyse whether the increased levels of endogenous c-jun in SCC cells are directly related to the low expression of sprr2, transient co-transfection assays of the sprr2a promoter-CAT construct with a vector expressing a mutant c-JUN protein (cJD6/194), which lacks the transcription activation domain (Angel et al., 1989) were performed. This class of c-jun mutants was previously shown to have a dominant negative phenotype (Brown et al., 1993) and to counteract both the high constitutive AP-1 activity and the tumorigenicity of malignant mouse keratinocytes (Domann et al., 1994a,b) . Whereas co-transfection with the control vector ( Figure 3B , bars 2, 6 and 10) or wild-type c-jun (bars 3, 7 and 11) had no signi®cant eect on CAT activity, co-transfection with the dominant negative mutant gave on average a 2.5-fold increase in sprr2a promoter activity in the three SCC cell lines tested (bars 4, 8 and 12).
As the sprr2a promoter contains an AP-1 binding sequence at position 7200 (Gibbs et al., 1990) we questioned whether this sequence is involved in the repression of sprr2a promoter activity by c-JUN. The experiments presented in Figure 3 show that this is not the case, as both the inhibition of promoter activity by c-JUN in normal cells ( Figure 3A , bars 6 and 7) and the restitution of this activity by mutant c-JUN in SCC lines ( Figure 3B , bars 13 and 14) are mediated via the 134 basepair-long minimal promoter present on plasmid pSG136, which does not contain the above mentioned sprr2a AP-1 binding site (Fischer et al., 1996) .
To make sure that the transient transfection experiments described above re¯ect the physiological behavior of the endogenous sprr2 promoter, we used retroviral transduction to construct an SCC cell line (derived from SCC12F2), constitutively expressing the dominant negative c-JUN mutant (F2D6) (Figure 4 . Normal human keratinocytes were isolated from neonatal human foreskin and cultured in standard medium in the presence of a 3T3 feeder layer as described previously (Gibbs et al., 1990) . Two weeks after reaching con¯uency, the strati®ed multilayer was detached with dispase, ®xed in 4% buered formaldehyde and embedded in paran as described (Ponec et al., 1989) . Sections of these cultures were incubated with speci®c antibodies and detected with the avidin biotin peroxidase complex method (DAKO). Sections were counterstained with haematoxylin and eosin (Merck). (b) Northern blot analysis of sprr2 (panel A) and cjun mRNA levels (panel B) after calcium induced strati®cation of normal human keratinocytes. The strati®cation assay is described in detail in Fischer et al. (1996) . At the indicated time points (in hours) after induction of strati®cation and terminal dierentiation, total RNA was isolated and processed for Northern blot analysis as previously described (Gibbs et al., 1990) . Each lane contains 20 mg of total RNA. 28S ribosomal RNA is used as a control for loading (panel C). Speci®c probes for sprr2 (Gibbs et al., 1993) and the N-terminal region of c-jun (HindIII/PstI) (Hattori et al., 1988) were labeled by random oligo priming and [a- Figure 3B ) suggest that the increased levels of sprr2 mRNA measured in cell line F2D6 are mainly due to increased transcription of the endogenous gene. An interesting observation in this experiment is that the expression of the involucrin gene, which codes for another precursor protein of the corni®ed cell envelope and was previously shown to be reduced in the SCC12F2 cell line (Rheinwald et al., 1983) , is also increased (to an even higher extent) in the F2D6 clone as compared to the control (Figure 4a ). These data strongly suggest that c-JUN is a general inhibitor of keratinocyte terminal dierentiation. A similar inverse relation between c-jun expression and dierentiation ability has also been described in a murine erythroleukemia cell line (Francastel et al., 1994) suggesting that the phenomenon might be even more general (see also promoter activity during calcium induced dierentiation in normal human keratinocytes. Sprr2a promoter activity was determined by measuring the CAT activity from either plasmid pSG122 which contains a 1500 bp promoter fragment (bars 1 ± 5) or from plasmid pSG136 which contains the 134 bp minimal sprr2a promoter (bars 6 and 7). pSG122 and pSG136 are identical to respectively pSG2 and pSG55 (Fischer et al., 1996) as far as the promoter insert is concerned, but dier from these plasmids by the presence of the sprr2a intron. Transfection of cells and induction of terminal dierentiation was performed by using the strati®cation assay as previously described (Fischer et al., 1996) . Bar 1: sprr2a promoter activity in monolayers of undierentiated basal keratinocytes; bars 2 and 6: sprr2a expression 24 h after calcium induced dierentiation; bars 3, 4 and 5: as for bar 2, but co-transfection of pSG122 with an RSV expression vector, containing either the neo gene (bar 3), the mutant c-jun gene (cJD6/194) (bar 4) or the wild-type c-jun gene (bar 5); bar 7 as for bar 6 but co-transfection of pSG136 with the RSV expression vector containing the wild-type c-jun gene. In all experiments 5 mg CAT reporter plasmid was cotransfected with 0.25 mg RSV expression plasmid. CAT-activity was determined by using the Fluor Diusion CAT assay. The average of three separate experiments is represented. (B) Restitution of sprr2a promoter activity by a dominant negative c-jun mutant in SCC12F2 (bars 1 ± 4), SCC4 (bars 5 ± 8) and SSC15 (bars 9 ± 14). CAT reporter plasmids were either pSG122 (bars 1 ± 12) or pSG136 (bars 13 and 14). In bars 1, 5, 9 and 13 no co-transfection with an expression plasmid was performed and the average promoter activity in these samples was put at 100% for each SCC cell line. Co-transfections were performed with the RSV vector expressing either the neo gene (bars 2, 6 and 10), the wild-type c-jun gene (bars 3, 7 and 11) or the dominant negative c-jun mutant cJD6/194 (bars 4, 8, 12 and 14) . SCC cells were grown in standard medium (without isoproterenol and EGF) on a 3T3 feeder layer to near con¯uency. After removal of the remaining 3T3's by aspiration with PBS/EDTA the cells were transfected in standard culture medium without growth factors with DOTAP (Boehringer) essentially as previously described for normal human keratinocytes (Fischer et al., 1996) . Promoter activity was determined 24 h after transfection and is derived from 2 ± 3 separate experiments At present it is not clear by which mechanism c-JUN inhibits the expression of keratinocyte terminal differentiation markers. Brown and co-workers (Brown et al., 1994) have proposed a quenching mechanism to explain the activity of their dominant c-JUN mutant. In this mechanism a dimer between mutant and wild-type c-JUN binds to an AP-1 site and competes with binding of normal dimers. We, however, found that the presence of the AP-1 site in the sprr2a promoter is not required for inhibition by c-JUN or reactivation by cJD6/194. Other researchers have shown that c-JUN can inhibit gene expression without the necessity of binding to DNA: Bois-Joyeux et al. (1995) demonstrated by in vitro footprinting that the rat a-fetoprotein promoter can be down-regulated by c-JUN without the need to bind to DNA. Bengal and co-workers (Bengal et al., 1992) showed that constitutive high expression of c-jun in myoblasts results in inhibition of myogenesis. In this case the inhibitory activity was due to direct physical association between c-JUN and MyoD. This physical interaction provides also an explanation for the mutual antagonism between these two transcriptional regulators. A similar cross-coupling has also been observed between c-JUN and the nuclear receptor family (Jonat et al., 1990) . Here mutual trans-repression appears to be mediated by a squelching mechanism involving the transcriptional co-activator CREB-binding protein (CBP) (Kamei et al., 1996) .
Consequently, inhibition of sprr2 expression by c-JUN might rely either on a direct physical interaction between c-JUN and the positive regulators of this gene, which bind to the proximal promoter (Fischer et al., 1996) , or by competition with a common transcriptional co-activator of low abundance. An indirect mechanism, where c-JUN would for instance induce a negative modulator of keratinocyte dierentiation, can however not be completely dismissed at this moment. More research is needed to unravel the molecular mechanism by which c-JUN antagonizes gene expression during keratinocyte terminal dierentiation. 
